Oxidative Stress Assay Market worth $1326 million by 2025 - Leading Key Players are Merck KGaA (Germany), Thermo Fisher Scientific Inc (US)

According to the new market research report "Oxidative Stress Assay Market by Product (Consumable, Instruments, Kits, Services), Test Type (Indirect, nucleic acid, Glutathione, ROS), Technology (ELISA, Chromatography), Diseases (CVD, Oncology) End Users (Pharma & Biotech) - Global Forecasts to 2025", published by MarketsandMarkets™, the Oxidative Stress Assay Market is projected to reach USD 1326 million by 2025 from USD 836 million in 2020, at a CAGR of 9.7%.

Browse in-depth TOC on "Oxidative Stress Assay Market"

206 – Tables
30 – Figures
189 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=223508598&utm_source=openpr&utm_medium=paidpr

The growth of this market is mainly driven by growth in the biopharmaceutical industry and increasing public-sector funding for academic research. Other important factors aiding the growth of this market include technological advancements like HCS for drug discovery, increasing R&D expenditure in biotechnology and pharmaceutical industries, and government support for pharmaceutical and biotechnology industries. On the other hand, the high cost of instruments and shortage of trained and qualified personnel are the major factors restraining the growth of this market.

The consumables segment accounted for the largest share of the oxidative stress assay market, by product, in 2020.

On the basis of product, the oxidative stress assay market is segmented into consumables, instruments, and services. Consumables is the largest and fastest-growing segment, in 2020. This segment is also projected to register the highest CAGR from 2020 to 2025. The recurring requirement of consumables as compared to instruments is the key factor driving the growth of this segment.

Pharmaceutical and biotechnology companies to grow at the highest CAGR in the oxidative stress assay market during the forecast period

The major end users of oxidative stress assays include academic research institutes, clinical laboratories, contract research organizations (CROs), pharmaceutical and biotechnology companies, and the cosmetic industry. Pharmaceutical and biotechnology companies are the largest end users of oxidative stress assays. These assays are widely used by pharmaceutical and biotechnology companies for the toxicity testing of drugs.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=223508598&utm_source=openpr&utm_medium=paidpr

North America will continue to dominate the oxidative stress assay market during the forecast period

On the basis of region, the market has been segmented into four major regions, namely, North America, Europe, the Asia Pacific, and Rest of the World. In 2020, North America accounted for the largest share of the market. The large share of North America can be attributed to the increasing geriatric population, increasing number of cardiovascular disease patients, and the presence of prominent players in the region.

Major players operating in the oxidative stress assay market include Abcam, plc (UK), Enzo Biochem, Inc. (US), Merck KGaA (Germany), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (US), AMS Biotechnology (Europe), Ltd. (UK), BioVision, Inc. (US), Cell Biolabs, Inc. (US), Oxford Biomedical Research (US), Promega Corporation (US), Cayman Chemical (US), Eagle Biosciences, Inc. (US), Arbor Assays (US), Hycult Biotech (Netherlands), Callegari SRL (Italy), Kamiya Biomedical Company (US), MEGA TIP San.Tic.Ltd.Sti. (Turkey), ImmunoChemistry Technologies, LLC (US), Genox Corporation (US), and Toxys B.V. (Netherlands).

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=223508598&utm_source=openpr&utm_medium=paidpr

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.